Allan Levey

Summary

Affiliation: Emory University
Country: USA

Publications

  1. ncbi Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease
    Allan Levey
    Department of Neurology and Alzheimer s Disease Center, Emory University School of Medicine, Atlanta, GA 30322, USA
    Clin Ther 28:991-1001. 2006
  2. ncbi Factors affecting survival of patients with neurodegenerative disease
    Kyle Steenland
    Department of Environmental and Occupational Health, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA
    Neuroepidemiology 35:28-35. 2010
  3. ncbi Late-life depression as a risk factor for mild cognitive impairment or Alzheimer's disease in 30 US Alzheimer's disease centers
    Kyle Steenland
    Department of Environmental and Occupational Health, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA
    J Alzheimers Dis 31:265-75. 2012
  4. ncbi The association between late-life depression, mild cognitive impairment and dementia: is inflammation the missing link?
    Adriana P Hermida
    Department of Psychiatry and Behavioral Science, Emory University School of Medicine, Wesley Woods Health Center, 4th Floor, 1841 Clifton Road, NE, Atlanta, GA 30329, USA
    Expert Rev Neurother 12:1339-50. 2012
  5. ncbi Recent trends in Alzheimer disease mortality in the United States, 1999 to 2004
    Kyle Steenland
    Department of Environmental and Occupational Health, Rollins School of Public Health, Emory University, 1518 Clifton Road, Atlanta, GA 30322, USA
    Alzheimer Dis Assoc Disord 23:165-70. 2009
  6. ncbi Vitamin E and donepezil for the treatment of mild cognitive impairment
    Ronald C Petersen
    Mayo Clinic College of Medicine, Rochester, Minn, USA
    N Engl J Med 352:2379-88. 2005
  7. ncbi Transgenic mice overexpressing reticulon 3 develop neuritic abnormalities
    Xiangyou Hu
    Department of Neurosciences, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    EMBO J 26:2755-67. 2007
  8. ncbi High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial
    Paul S Aisen
    Department of Neurosciences, University of California, San Diego, 9500 Gilman Dr, M C 0949, La Jolla, CA 92093, USA
    JAMA 300:1774-83. 2008

Detail Information

Publications8

  1. ncbi Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease
    Allan Levey
    Department of Neurology and Alzheimer s Disease Center, Emory University School of Medicine, Atlanta, GA 30322, USA
    Clin Ther 28:991-1001. 2006
    ..Ongoing research is focusing on the identification of those individuals with mild cognitive impairment (MCI) who are most likely to convert to AD. Of the MCI subtypes, patients with amnestic MCI (a-MCI) are at greatest risk...
  2. ncbi Factors affecting survival of patients with neurodegenerative disease
    Kyle Steenland
    Department of Environmental and Occupational Health, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA
    Neuroepidemiology 35:28-35. 2010
    ..Survival varies widely among different neurodegenerative diseases. Data on the role of the Mini Mental State Examination (MMSE) and apolipoprotein E (APOE) in survival are sparse except for Alzheimer's disease (AD)...
  3. ncbi Late-life depression as a risk factor for mild cognitive impairment or Alzheimer's disease in 30 US Alzheimer's disease centers
    Kyle Steenland
    Department of Environmental and Occupational Health, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA
    J Alzheimers Dis 31:265-75. 2012
    ..The effect of recent depression did not differ by antidepressant treatment, APOE4 allele status, or type of MCI. In conclusion, late-life depression is a strong risk factor for normal subjects progressing to MCI...
  4. ncbi The association between late-life depression, mild cognitive impairment and dementia: is inflammation the missing link?
    Adriana P Hermida
    Department of Psychiatry and Behavioral Science, Emory University School of Medicine, Wesley Woods Health Center, 4th Floor, 1841 Clifton Road, NE, Atlanta, GA 30329, USA
    Expert Rev Neurother 12:1339-50. 2012
    ..The diagnostic challenges, the importance of biomarkers and the discussion of inflammation as a possible link between depression, MCI and dementia are examined in this article...
  5. ncbi Recent trends in Alzheimer disease mortality in the United States, 1999 to 2004
    Kyle Steenland
    Department of Environmental and Occupational Health, Rollins School of Public Health, Emory University, 1518 Clifton Road, Atlanta, GA 30322, USA
    Alzheimer Dis Assoc Disord 23:165-70. 2009
    ..AD reporting on death certificates is known to be poor. This is the first analysis of recent trends in AD mortality since the advent of ICD-10...
  6. ncbi Vitamin E and donepezil for the treatment of mild cognitive impairment
    Ronald C Petersen
    Mayo Clinic College of Medicine, Rochester, Minn, USA
    N Engl J Med 352:2379-88. 2005
    ....
  7. ncbi Transgenic mice overexpressing reticulon 3 develop neuritic abnormalities
    Xiangyou Hu
    Department of Neurosciences, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    EMBO J 26:2755-67. 2007
    ..Together, we demonstrate that aggregation of RTN3 contributes to AD pathogenesis by inducing neuritic dystrophy. Inhibition of RTN3 aggregation is likely a therapeutic approach for reducing neuritic dystrophy...
  8. ncbi High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial
    Paul S Aisen
    Department of Neurosciences, University of California, San Diego, 9500 Gilman Dr, M C 0949, La Jolla, CA 92093, USA
    JAMA 300:1774-83. 2008
    ..Prior studies of B vitamins to reduce homocysteine in AD have not had sufficient size or duration to assess their effect on cognitive decline...